- Accesswire•2 days agoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of Fiduciary Duty by the Board of Sorrento Therapeutics, Inc. - SRNE
NEW YORK, NY / ACCESSWIRE / August 23, 2016 / Levi & Korsinsky announces it has commenced an investigation of Sorrento Therapeutics, Inc. (NASDAQ: SRNE) concerning possible breaches of fiduciary duty by ...
- PR Newswire•2 days agoSHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Sorrento Therapeutics, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
NEW YORK, Aug. 23, 2016 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim ...
- The Wall Street Journal•8 days ago
Semnur Pharmaceuticals Inc., a venture-backed company developing a treatment for intractable cancer pain, is being acquired for up to $200 million.
Sorrento Therapeutics, Inc. (SRNE)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
|Bid||6.00 x 100|
|Day's Range||6.40 - 7.20|
|52wk Range||4.25 - 13.91|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-2.92|
|Avg Vol (3m)||189,935|
|Dividend & Yield||N/A (N/A)|